Collection and Distribution of Samples From Healthy Donors for In Vitro Research at the NCI-Frederick

Enrolling by invitation

Conditions studied: Healthy Donors

In brief

Background -NCI-Frederick scientists performing in vitro studies involving human specimens have a need for a reliable and consistent source of samples which protects the donor from research risks. Objective -The purpose of this protocol is to establish a centralized repository for the collection and distribution of samples (either blood, buccal mucosal cells, semen, urine, or nail clippings) from paid, healthy volunteer donors for in vitro research conducted by NIH investigators located at NCI-Frederick and Ft. Detrick. Research will include, but are not limited to, genotype analysis, immune function studies, drug screening, vaccine development, method development, quality control testing of reagents, and propagation of infectious agents, including HIV. Eligibility: Healthy NCI-Frederick employees and other NIH staff located at Ft. Detrick will be recruited. Potential donors will be excluded if screening indicates exposure to HIV, HTLV, Hepatitis C or Hepatitis B virus infection. Study Design: Investigators requesting to participate to the Research Donor Program (RDP) by receiving samples for research use will be required to submit a written memo of request, briefly describing the nature of the research and providing assurance that samples provided through this protocol will be used solely for in vitro research. These Investigators will receive samples that will be either anonymous or coded, depending on the specific need. Codes will be securely maintained and under no circumstances will donor identity be released to Investigators. Donors will receive financial compensation for their time, discomfort and inconvenience according to an established schedule; compensation for blood donation is based on the volume donated.

Key facts

Study ID

NCT00339911

Run by

National Cancer Institute (NCI)

People needed

1200

Starts

1999-11-01

Expected to finish

2030-10-13

Last updated by the study team

2026-08-04

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: accepted.

You may not qualify if…

• Individuals with any of the following will be excluded from the donor pool:
• History of chronic illness that might increase the risks associated with phlebotomy, including but not limited to heart, lung, or kidney disease
• Current acute illness.
• History of clotting disorders.
• Current medications which might increase the risks associated with phlebotomy.
• History of syncope or other difficulty with venipuncture.
• Anemia, as determined by hematocrit or hemoglobin.
• Hematocrit Acceptable range for males: 40-51 percent.
• Hematocrit Acceptable range for females: 34-46 percent.
• Hemoglobin Acceptable range for males: 12.5-17.0 g/dl
• Hemoglobin Acceptable range for females: 11.5-15.2 g/dl
• Positive blood test for exposure to HIV-1, HIV-2, HTLV-1, HTLV-2, or HCV or for HBV surface antigens.
• Individuals whose activities or conditions place them at high risk of HIV infection are asked not to donate.
• Males who qualify for participation in the donor pool will be excluded from participation in semen donation if they have knowingly had any injury, infection, or treatment performed that renders them incapable of producing sperm.
• Pregnancy: Pregnant women will not be allowed to enroll in this study because there is no benefit.

Where it is running

• NCI Frederick Cancer Research Center — Frederick, Maryland, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.